title: Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals.
abstract: This study was initiated to find small molecule ligands that would induce a functional response when docked with neurotrophin Trk receptors. "Minimalist" mimics of beta-turns were designed for this purpose. These mimics are (i) rigid, yet easily folded into turn-like conformations, and (ii) readily accessible from amino acids bearing most of the natural side chains. Gram quantities of 16 of these turn mimics were prepared and then assembled into 152 fluorescein-labeled bivalent peptidomimetics via a solution-phase combinatorial method. Fluorescence-based screening of these molecules using cells transfected with the Trk receptors identified 10 potential ligands of TrkC, the receptor for neurotrophin-3. Analogues of these bivalent peptidomimetics with biotin replacing the fluorescein label were then prepared and tested to confirm that binding was not due to the fluorescein. Several assays were conducted to find the mode of action of these biotinylated compounds. Thus, direct binding, survival and neuritogenic, and biochemical signal transduction assays showed 8 of the original 10 hits were agonistic ligands binding to the ectodomain of TrkC. Remarkably, some peptidomimetics afford discrete signals leading to either cell survival or neuritogenic differentiation. The significance of this work is three-fold. First, we succeeded in finding small, selective, proteolytically stable ligands for the TrkC receptor; there are very few of these in the literature. Second, we show that it is possible to activate distinct and biased signaling pathways with ligands binding at the ectodomain of wild-type receptors. Third, the discovery that some peptidomimetics initiate different modes of cell signaling increases their potential as pharmacological probes and therapeutic leads.
authors.affiliation: Department of Chemistry, Texas A & M University, Box 30012, College Station, Texas 77841.
authors.forename: Dianjun
authors.initials: D
authors.lastname: Chen
authors.forename: Fouad
authors.initials: F
authors.lastname: Brahimi
authors.forename: Yu
authors.initials: Y
authors.lastname: Angell
authors.forename: Yu-Chin
authors.initials: YC
authors.lastname: Li
authors.forename: Jennifer
authors.initials: J
authors.lastname: Moscowicz
authors.forename: H Uri
authors.initials: HU
authors.lastname: Saragovi
authors.forename: Kevin
authors.initials: K
authors.lastname: Burgess
mesh_terms: D000818:Animals; D032701:Biomimetics; D002470:Cell Survival / Q000187:drug effects; D008024:Ligands; D051379:Mice; D041681:NIH 3T3 Cells; D055495:Neurogenesis / Q000187:drug effects*; D020933:Neurotrophin 3 / Q000378:metabolism*; D011485:Protein Binding; D020812:Receptor, trkC / Q000819:agonists* / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects; D054852:Small Molecule Libraries / Q000737:chemistry* / Q000494:pharmacology*; D014162:Transfection
chemical_list: D008024:Ligands; D020933:Neurotrophin 3; D054852:Small Molecule Libraries; D020812:Receptor, trkC